Abstract

Skeletal muscle atrophy is a major consequence of several pathophysiological conditions, including neuromuscular diseases, disuse (limb immobilization, space flight), aging (sarcopenia) and other wasting conditions (i.e. cancer cachexia). Basically, a disequilibrium between anabolic/catabolic pathways leads to progressive loss of muscle mass and functional impairment. The aim of translational research in this field is to identify anabolic compounds able to support protein synthesis and muscle mass, restoring muscle function and metabolism. Therefore, the validation of adequate readout parameters to assess atrophy and efficacy of therapeutics in reliable animal models is pivotal. Here, we focused on a detailed preclinical investigation of the hind limb unloading (HU) murine model, in which disuse leads to severe atrophy, dysfunction and damage in postural soleus (SOL) muscle. 10-week-old, male C57BL/6J mice underwent a 2-week HU protocol (T0–T2), in comparison to age-, sex-matched non-HU mice for a wide array of in vivo/ex vivo outcomes. At T0 (pre-HU), all mice had comparable body weight (BW). At T2, HU mice BW was significantly lower with respect to T0 (-9.7%) and to non-HU mice (-17.3%). We disclosed for the first time that in vivo torque of hind limb plantar flexor muscles (i.e. SOL, gastrocnemius) was severely impaired in HU mice, as well as SOL muscle contractile and elastic properties, measured ex vivo. This was paralleled by a significant decrease in SOL muscle mass (-39%) and total protein content (-47%). SOL muscle histology was also seriously compromised by HU protocol, with clear signs of myofiber damage and atrophy (significant decrease in fiber cross-sectional area vs non-HU condition). Finally, we found a remarkable -61% reduction of salivary IgA levels, which suggests a HU-induced negative immune response modulation, in line with previous observations from other models of hind limb suspension. Overall, our findings support the usefulness of the HU mouse model for preclinical translational research on skeletal muscle atrophy.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.